Clearpoint Neuro
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,122 | $7,858 | $7,639 | $6,810 |
Gross Profit | 4,847 | 4,988 | 4,525 | 4,013 |
EBITDA | -5,172 | -4,276 | -3,672 | -4,195 |
EBIT | -4,739 | -4,146 | -4,619 | |
Net Income | -4,974 | -4,408 | -4,146 | -4,619 |
Net Change In Cash | 8,122 | 7,858 | 7,639 | 6,810 |
Free Cash Flow | -1,211 | -2,668 | -3,840 | -1,357 |
Cash | 21,573 | 32,845 | 35,353 | 23,140 |
Basic Shares | 27,591 | 27,468 | 25,452 | 24,628 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $23,955 | $20,551 | $16,299 | $12,829 |
Gross Profit | 13,614 | 13,531 | 11,291 | 9,120 |
EBITDA | -20,989 | -15,577 | -12,745 | -4,788 |
EBIT | -22,446 | -16,354 | -13,437 | -5,338 |
Net Income | -22,089 | -16,538 | -15,320 | -9,108 |
Net Change In Cash | 23,955 | 20,551 | 16,299 | 12,829 |
Cost of Revenue | -26,494 | 34,010 | 14,403 | |
Free Cash Flow | -14,771 | -17,313 | -12,865 | -8,290 |
Cash | 23,140 | 27,615 | 54,109 | 20,099 |
Basic Shares | 24,605 | 24,181 | 20,734 | 15,849 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.18 |
2024-06-30 | -$0.16 |
2024-03-31 | -$0.16 |
2023-12-31 | -$0.19 |
